Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1984 Mar;55(3):655–663.

Spontaneous suppressor cell activity in the peripheral blood of patients with malignant and chronic inflammatory bowel diseases.

K Doldi, B Manger, B Koch, J Riemann, P Hermanek, J R Kalden
PMCID: PMC1535940  PMID: 6231146

Abstract

Fifteen patients with colorectal tumours, 15 patients with Crohn's disease (CD) and two groups of normal controls were investigated for the presence of spontaneous suppressor cell activity (SSCA) in peripheral blood mononuclear cells (PBMC). In comparison to the age and sex matched controls patients with colorectal carcinoma exhibited a significant increase in SSCA (P less than 0.01). No evidence could be obtained that the suppressive effect was due to a soluble factor such as prostaglandins. In contrast, patients suffering from CD presented a decreased SSCA. No correlation was obtained between the enhanced SSCA in tumour patients and the clinical stage of the disease, levels of oncofetal antigens or serum immune complexes. Likewise in patients with CD no correlation was found between decreased SSCA and CD index or different serum parameters. When PBMC of the different test groups were incubated with histamine or cimetidine before they were added to the indicator system the suppressive activity remained unchanged. Also pre-incubation of normal PBMC with alpha-fetoprotein or carcinoembryonic antigen did not change the spontaneous suppressor cell activity. Whether the significantly enhanced in vivo activity of spontaneous suppressor cells in patients with colorectal carcinoma is one of the multifactorial mechanisms leading to the establishment of cancer or whether it rather represents a reflection of the immune system on colorectal tumour antigens remains unsolved.

Full text

PDF
655

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auer I. O., Buschmann C., Ziemer E. Immune status in Crohn's disease. 2. Originally unimpaired primary cell mediated immunity in vitro. Gut. 1978 Jul;19(7):618–626. doi: 10.1136/gut.19.7.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Best W. R., Becktel J. M., Singleton J. W., Kern F., Jr Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976 Mar;70(3):439–444. [PubMed] [Google Scholar]
  3. Broder S., Muul L., Waldmann T. A. Suppressor cells in neoplastic disease. J Natl Cancer Inst. 1978 Jul;61(1):5–11. doi: 10.1093/jnci/61.1.5. [DOI] [PubMed] [Google Scholar]
  4. Colley D. G., Lewis F. A., Goodgame R. W. Immune responses during human schistosomiasis mansoni. IV. Induction of suppressor cell activity by schistosome antigen preparations and concanavalin A. J Immunol. 1978 Apr;120(4):1225–1232. [PubMed] [Google Scholar]
  5. Dosch H. M., Gelfand E. W. Functional differentiation of B lymphocytes in agammaglobulinemia. III. Characterization of spontaneous suppressor cell activity. J Immunol. 1978 Nov;121(5):2097–2105. [PubMed] [Google Scholar]
  6. Dwyer J. M., Johnson C. The regulation of T cell responses by spontaneously active suppressor cells. Clin Exp Immunol. 1982 Nov;50(2):406–415. [PMC free article] [PubMed] [Google Scholar]
  7. Fujimoto S., Greene M. I., Sehon A. H. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts. J Immunol. 1976 Mar;116(3):791–799. [PubMed] [Google Scholar]
  8. Fujimoto S., Greene M. I., Sehon A. H. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts. J Immunol. 1976 Mar;116(3):800–806. [PubMed] [Google Scholar]
  9. Gifford R. R., Sr, Hatfield S. M., Schmidtke J. R. Cimetidine-induced augmentation of human lymphocyte blastogenesis by mitogen, bacterial antigen, and alloantigen. Transplantation. 1980 Feb;29(2):143–148. doi: 10.1097/00007890-198002000-00011. [DOI] [PubMed] [Google Scholar]
  10. Goodacre R. L., Bienenstock J. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease. Gastroenterology. 1982 Apr;82(4):653–658. [PubMed] [Google Scholar]
  11. Goodwin J. S., DeHoratius R., Israel H., Peake G. T., Messner R. P. Suppressor cell function in sarcoidosis. Ann Intern Med. 1979 Feb;90(2):169–173. doi: 10.7326/0003-4819-90-2-169. [DOI] [PubMed] [Google Scholar]
  12. Gupta S., Good R. A. Alpha-fetoprotein and human lymphocyte subpopulations. J Immunol. 1977 Feb;118(2):405–408. [PubMed] [Google Scholar]
  13. Hermanek P., Gall F. P., Altendorf A. Prognostic groups in colorectal carcinoma. J Cancer Res Clin Oncol. 1980;98(2):185–193. doi: 10.1007/BF00405962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kalden J. R., Peter H. H., Roubin R., Cesarini J. P. Human peripheral Null lymphocytes. I. Isolation, immunological and functional characterization. Eur J Immunol. 1977 Aug;7(8):537–543. doi: 10.1002/eji.1830070809. [DOI] [PubMed] [Google Scholar]
  15. Kirchner H., Muchmore A. V., Chused T. M., Holden H. T., Herberman R. B. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice. J Immunol. 1975 Jan;114(1 Pt 1):206–210. [PubMed] [Google Scholar]
  16. Klajman A., Farkas R., Drucker I., Schneider M., Becker M., Man B., Reiss R. T-cell-mediated cytotoxicity in patients with colorectal cancer. Clin Immunol Immunopathol. 1980 Nov;17(3):335–343. doi: 10.1016/0090-1229(80)90105-1. [DOI] [PubMed] [Google Scholar]
  17. Krapf F., Renger D., Schedel I., Leiendecker K., Leyssens H., Deicher H. A PEG-precipitation laser nephelometer technique for detection and characterization of circulating immune complexes in human sera. J Immunol Methods. 1982 Oct 15;54(1):107–117. doi: 10.1016/0022-1759(82)90119-3. [DOI] [PubMed] [Google Scholar]
  18. Meretey K., Room G., Maini R. N. Effect of histamine on the mitogenic response of human lymphocytes and its modification by cimetidine and levamisole. Agents Actions. 1981 Apr;11(1-2):84–88. doi: 10.1007/BF01991465. [DOI] [PubMed] [Google Scholar]
  19. Murgita R. A., Goidl E. A., Kontianen S., Wigzell H. alpha-Fetoprotein induces suppressor T cells in vitro. Nature. 1977 May 19;267(5608):257–259. doi: 10.1038/267257a0. [DOI] [PubMed] [Google Scholar]
  20. Ogden B. E., Hill H. R. Histamine regulates lymphocyte mitogenic responses through activation of specific H1 and H2 histamine receptors. Immunology. 1980 Sep;41(1):107–114. [PMC free article] [PubMed] [Google Scholar]
  21. Patt Y. Z., Hersh E. M., Dicke K., Spitzer G., Mavligit G. M. Suppressor cell activity in cancer patients: a possible role for thymic hormones. Cancer Treat Rep. 1978 Nov;62(11):1763–1768. [PubMed] [Google Scholar]
  22. Pfreundschuh M., Bader B., Feurle G. E. T-lymphocyte subpopulations in Crohn's disease: definition by monoclonal antibodies. Klin Wochenschr. 1982 Nov 2;60(21):1369–1371. doi: 10.1007/BF01716217. [DOI] [PubMed] [Google Scholar]
  23. Rocklin R. E., Haberek-Davidson A. Histamine activates suppressor cells in vitro using a coculture technique. J Clin Immunol. 1981 Jan;1(1):73–79. doi: 10.1007/BF00915479. [DOI] [PubMed] [Google Scholar]
  24. Thomas Y., Huchet R., Granjon D. Histamine-induced suppressor cells of lymphocyte mitogenic response. Cell Immunol. 1981 Apr;59(2):268–275. doi: 10.1016/0008-8749(81)90408-1. [DOI] [PubMed] [Google Scholar]
  25. Tosato G., Magrath I., Koski I., Dooley N., Blaese M. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis. N Engl J Med. 1979 Nov 22;301(21):1133–1137. doi: 10.1056/NEJM197911223012101. [DOI] [PubMed] [Google Scholar]
  26. Victorino R. M., Hodgson H. J. Alteration in T lymphocyte subpopulations in inflammatory bowel disease. Clin Exp Immunol. 1980 Jul;41(1):156–165. [PMC free article] [PubMed] [Google Scholar]
  27. Victorino R. M., Hodgson H. J. Spontaneous suppressor cell function in inflammatory bowel disease. Dig Dis Sci. 1981 Sep;26(9):801–806. doi: 10.1007/BF01309612. [DOI] [PubMed] [Google Scholar]
  28. Waldmann T. A., Broder S. Suppressor cells in the regulation of the immune response. Prog Clin Immunol. 1977;3:155–199. [PubMed] [Google Scholar]
  29. Zembala M., Mytar B., Popiela T., Asherson G. L. Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells. Int J Cancer. 1977 May 15;19(5):605–613. doi: 10.1002/ijc.2910190503. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES